Revvity unveils a new era of automated tuberculosis testing

New and improved workflow now available that pairs Revvity’s T-SPOT.TB test with the Auto-Pure 2400 liquid handling platform.
May 3, 2024

Revvity, Inc. announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test.

Auto-Pure 2400 liquid handler for use with the T-SPOT.TB test:

  • The Auto-Pure 2400 automated liquid handling platform is equipped with integrated magnetic cell isolation technology.
  • Designed for testing up to 24 samples per run, it completes day-1 T-SPOT.TB workflows in under 3.5 hours, requiring only a single mid-run user interaction.

About the T-SPOT.TB test:

  • The T-SPOT.TB test detects latent tuberculosis infection (LTBI) and is an interferon-gamma release assay (IGRA) based on the enzyme-linked immunospot (ELISPOT) technology.
  • Steps include washing, isolating, and counting peripheral blood mononuclear cells (PBMCs) before conducting the test.

Revvity release

About the Author

Sign up for our eNewsletters
Get the latest news and updates